Boston Scientific Corporation (B1SX34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 21 Oct 2026
Key indicators
| Last close | BRL 55.86 |
|---|---|
| 52-week range | 50.29 – 140.91 |
| Return, 1 month / 3 months | +0.4% / +1.8% |
| Return, 1 year / 3 years | −57.9% / −17.0% |
| Trend | Below its 200-day average |
| RSI (14) | 48 |
| Volatility (1 year) | 41.4% |
| Worst drawdown (1 year) | -62.6% |
| Average daily value traded | 0.19M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Boston Scientific Corporation develops and manufactures medical devices used by hospitals, clinics and physicians around the world. Its products include stents and catheters for heart and vascular conditions, pacemakers and defibrillators for heart rhythm problems, and instruments used in endoscopy and other minimally invasive procedures. The company is based in Marlborough, Massachusetts, in the United States, and its devices are used in many countries across the Americas, Europe and Asia.
Boston Scientific Corporation is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code B1SX34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Boston Scientific Corporation (B1SX34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 55.86 on 21 October 2026.
Its price-based Market X-Ray is 27 out of 100 (a weak price profile), ranking 1,262 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 57.9% and over the last three months it rose 1.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 7 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -26.2% | ||
| From 52-week high | -60.0% | ||
| Momentum | 19 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 1.8% | ||
| 6-month return | -30.4% | ||
| 12-month return, skipping the last month | -58.1% | ||
| Stability (higher is calmer) | 30 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 41.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -62.6% | ||
| Liquidity | 68 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.19M BRL | ||
| Zero-volume days | 8.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +2.0% |
|---|---|
| 1 month | +0.4% |
| 3 months | +1.8% |
| 6 months | −30.4% |
| 1 year | −57.9% |
| 3 years | −17.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 58.92 / 75.66 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.15 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.